See All News - tctmd.com

News

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Conference News TCT 2012

Combination N-Acetylcysteine, Sodium Bicarbonate Fails to Significantly Lower Acute CIN

October 24, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Conference News TCT 2012

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

News Conference News TCT 2012

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

October 24, 2012

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

News Conference News TCT 2012

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

October 23, 2012

Advertisement

News

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

Combination N-Acetylcysteine, Sodium Bicarbonate Fails to Significantly Lower Acute CIN

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content